CEACAM5 and neoplasm: Through a multicenter clinical study with large samples, we found that serum tumor markers, especially CEA combined with CYFRA21‐1, could effectively predict the concordance rates between plasma and tissue biopsies, and provided a predictive model of serum tumor markers for clinicians to quickly and accurately identify patients who are suitable for plasma biopsy for genotyping first.